Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment
Crossref DOI link: https://doi.org/10.1186/s40425-017-0282-x
Published Online: 2017-10-17
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Anderson, Erik S.
Postow, Michael A.
Wolchok, Jedd D.
Young, Robert J.
Ballangrud, Åse
Chan, Timothy A.
Yamada, Yoshiya
Beal, Kathryn